The potential for intensified gastrointestinal side effects and erratic blood glucose levels highlights the importance of careful management and consultation with healthcare providers
doi: 10.1111/imj.15967 14 IyengarJ
8:23-cv-1, accessed December 19, 2025, Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded semaglutide PR Newswire, accessed December 19, 2025, Novo Nordisk v
doi: 10.3389/fbioe.2023.1161472 Received 08 February 2023 Accepted 24 February 2023 Published 10 March 2023 Volume 11 - 2023 Edited by Wen Sun, Dalian University of Technology, China Reviewed by Xin Liu, The University of Chicago, United States Xiaobo Wang, Fourth Military Medical University, China Updates Copyright 2023 Liu, Hao, Liu and Hu
Hair gains have held steady through the breaks, which was a concern initially